UROwebinar: Defining complete response in MIBC after systemic neoadjuvant and adjuvant therapies
In this UROwebinar by the European School of Urology and the EAU Section of Urological Imaging, the international experts will provide the latest updates on imaging and biomarkers for muscle-invasive bladder cancer (MIBC) treatment.
| Organiser | European School of Urology |
|---|---|
| CME | 1.00 |
| Location | Online |
The management of MIBC is rapidly evolving with the increasing use of neoadjuvant and adjuvant systemic therapies. However, defining a true complete response after treatment remains a major clinical challenge.
In this UROwebinar, international experts will discuss current evidence on MRI and PET imaging, and biomarkers such as ctDNA, to assess treatment response and guide subsequent management in MIBC
Faculty
Prof. Dr. A. Van Der Heijden (NL)
Speaker
Prof. V. Panebianco (IT)
Speaker
Prof. Dr. D. Oprea-Lager (NL)
Speaker
Prof. Dr. A. Heidenreich (DE)
Speaker